News

Pharmabiz17h
Marengo begins patient dosing in STARt-002 phase 1b/2 study of invikafusp alfa in combo with TROP2-directed ADC Trodelvy in metastatic breast cancer
Cambridge, Massachusetts Saturday, May 10, 2025, 18:00 Hrs [IST] ...
Pharmabiz20h
Amneal & Apiject to expand sterile and blow-fill-seal capabilities for advanced pharmaceutical manufacturing in US
Bridgewater, New Jersey Saturday, May 10, 2025, 15:00 Hrs [IST] ...
Pharmabiz21h
NIH study shows incidence rates of some cancer types have risen in people under age 50
Bethesda, Maryland Saturday, May 10, 2025, 14:00 Hrs [IST] ...
Pharmabiz19h
5th Annual Pharma GMP & Quality Management 2025 empowers industry
Industry leaders, innovators, and regulators converged to explore the future of quality, compliance, and digital transformation in life sciences at the 5th Annual Pharma GMP & Quality Management 2025 ...
Pharmabiz22h
US FDA approves Verastem’s Avmapki Fakzynja combo therapy to treat patients with KRAS-mutated recurrent low-grade serous ovarian cancer
US FDA approves Verastem’s Avmapki Fakzynja combo therapy to treat patients with KRAS-mutated recurrent low-grade serous ovarian cancer: Boston Saturday, May 10, 2025, 13:00 Hrs ...
Pharmabiz23h
OmRx Oncology begins phase 2 trial of oral PD-L1 inhibitor OX-4224 in patients with non-small cell lung cancer
OmRx Oncology begins phase 2 trial of oral PD-L1 inhibitor OX-4224 in patients with non-small cell lung cancer: San Diego Saturday, May 10, 2025, 12:00 Hrs [IST] OmRx Oncology, or ...
Pharmabiz23h
Majority of micro and small units fails to apply for Schedule M timeline extension, says section of industry
Our Bureau, New Delhi Saturday, May 10, 2025, 12:30 Hrs [IST] ...